Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DBV Technologies S.A. | 964,000 | reported | 21 Nov 2025 | tx 6+3,639,352 |
| Bellerophon Therapeutics, Inc. | 182,604 | reported | 21 Jun 2018 | tx 7+136,922 |
| REGENXBIO Inc. | 19,054 | reported | 30 May 2025 | tx 14+196,539 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Nov 2025 | GRANT_AWARD | DBV Technologies S.A. | 964,000 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 7,768 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 39,815 | 0.00 USD | deriv |
| 04 Dec 2024 | GRANT_AWARD | DBV Technologies S.A. | 813,200 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 4,790 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 24,454 | 0.00 USD | deriv |
| 08 Mar 2024 | PURCHASE | DBV Technologies S.A. | 17,094 | 0.83 USD | first after silence |
| 20 Nov 2023 | GRANT_AWARD | DBV Technologies S.A. | 806,672 | 0.00 USD | deriv |
| 21 Nov 2022 | GRANT_AWARD | DBV Technologies S.A. | 764,386 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | REGENXBIO Inc. | 3,486 | 0.00 USD | |
| 02 Jun 2023 | GRANT_AWARD | REGENXBIO Inc. | 17,892 | 0.00 USD | deriv |
| 03 Jun 2022 | GRANT_AWARD | REGENXBIO Inc. | 3,010 | 0.00 USD | |
| 03 Jun 2022 | GRANT_AWARD | REGENXBIO Inc. | 15,324 | 0.00 USD | deriv |
| 22 Nov 2021 | GRANT_AWARD | DBV Technologies S.A. | 274,000 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 29 May 2020 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 31 May 2019 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 21 Jun 2018 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 11,987 | 0.00 USD | |
| 05 Jun 2018 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 38,216 | 2.27 USD | deriv |
| 25 May 2018 | GRANT_AWARD | REGENXBIO Inc. | 12,500 | 0.00 USD | deriv |
| 22 Sept 2017 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 28 Jun 2017 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 25,363 | 0.00 USD | |
| 24 May 2017 | GRANT_AWARD | REGENXBIO Inc. | 12,500 | 0.00 USD | deriv |
| 15 Aug 2016 | GRANT_AWARD | REGENXBIO Inc. | 25,000 | 0.00 USD | deriv |
| 17 Jun 2016 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Mar 2024.